{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:08:23Z","timestamp":1779167303186,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.transproceed.2026.02.014","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:01:29Z","timestamp":1772600489000},"page":"436-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["In Hepatitis C Virus\u2013Negative Recipients of a Hepatitis C Virus\u2013Infected Donor Kidney, Direct Antiviral Agent Therapy for 8 Weeks Is Noninferior to 12 Weeks"],"prefix":"10.1016","volume":"58","author":[{"given":"Sandeep","family":"Khurana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Gaines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9898-3484","authenticated-orcid":false,"given":"Deepa","family":"Kumarjiguda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Kotru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Marvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benyam","family":"Addissie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2026.02.014_bib0001","series-title":"Global Observatory on Donation and Transplantation","article-title":"International report on organ donation and transplantation activities. Executive summary","year":"2019"},{"issue":"3","key":"10.1016\/j.transproceed.2026.02.014_bib0002","doi-asserted-by":"crossref","first-page":"e1450","DOI":"10.1097\/TXD.0000000000001450","article-title":"Normothermic regional perfusion can improve both utilization and outcomes in DCD liver, kidney, and pancreas transplantation","volume":"9","author":"Bekki","year":"2023","journal-title":"Transplant Direct"},{"issue":"1","key":"10.1016\/j.transproceed.2026.02.014_bib0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1515\/jtim-2017-0007","article-title":"Direct acting anti-hepatitis C virus drugs: clinical pharmacology and future direction","volume":"5","author":"Geddawy","year":"2017","journal-title":"J Transl Int Med"},{"issue":"24","key":"10.1016\/j.transproceed.2026.02.014_bib0004","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","author":"Goldberg","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.transproceed.2026.02.014_bib0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: an open-label nonrandomized trial","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.transproceed.2026.02.014_bib0006","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection","volume":"71","author":"Ghany","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.transproceed.2026.02.014_bib0007","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.31011","article-title":"Hepatitis C virus NAT-positive solid organ allografts transplanted into hepatitis C virus-negative recipients: a real-world experience","volume":"72","author":"Kapila","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.transproceed.2026.02.014_bib0008","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M20-1468","article-title":"Four-week direct-acting antiviral prophylaxis for kidney transplantation from hepatitis C-viremic donors to hepatitis C-negative recipients: an open-label nonrandomized study","volume":"174","author":"Durand","year":"2021","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.transproceed.2026.02.014_bib0009","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/ajt.15664","article-title":"Ultra-short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients","volume":"20","author":"Gupta","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2026.02.014_bib0015","doi-asserted-by":"crossref","unstructured":"Johansen KL, Chertow GM, Foley RN, Gilbertson DT, Herzog CA, Ishani A, et al. US Renal Data System 2020 Annual Data Report: Epidemiology of kidney disease in the United States. Am J Kidney Dis 2021;77(4 Suppl 1):A7\u2013A8.","DOI":"10.1053\/j.ajkd.2021.01.002"},{"issue":"6","key":"10.1016\/j.transproceed.2026.02.014_bib0016","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.kint.2021.06.034","article-title":"A review of kidney transplantation from HCV-viremic donors into HCV-negative recipients","volume":"100","author":"Daloul","year":"2021","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.transproceed.2026.02.014_bib0017","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/M18-0749","article-title":"Twelve-month outcomes after transplant of hepatitis C-infected kidneys into uninfected recipients: a single-group trial","volume":"169","author":"Reese","year":"2018","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.transproceed.2026.02.014_bib0018","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/jama.2022.12868","article-title":"Five-year allograft survival for recipients of kidney transplants from hepatitis C virus infected vs uninfected deceased donors in the direct-acting antiviral therapy era","volume":"328","author":"Schaubel","year":"2022","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.transproceed.2026.02.014_bib0019","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/ajt.15583","article-title":"Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: a unique complication in the DAA era","volume":"20","author":"Kapila","year":"2020","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.transproceed.2026.02.014_bib0020","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhep.2020.11.005","article-title":"Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients","volume":"74","author":"Aqel","year":"2021","journal-title":"J Hepatol"},{"issue":"Suppl 7","key":"10.1016\/j.transproceed.2026.02.014_bib0021","first-page":"S850","article-title":"Renal replacement therapy for renal transplant recipients during ICU stay","volume":"102","author":"Gedik","year":"2018","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.transproceed.2026.02.014_bib0022","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.chest.2016.01.002","article-title":"The critically ill kidney transplant recipient: a narrative review","volume":"149","author":"Canet","year":"2016","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.transproceed.2026.02.014_bib0023","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2019.11.005","article-title":"Cost-effectiveness of using kidneys from HCV-viremic donors for transplantation into HCV-uninfected recipients","volume":"75","author":"Eckman","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.transproceed.2026.02.014_bib0024","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/ajt.14454","article-title":"Integrating kidney transplantation into value-based care for people with renal failure","volume":"18","author":"Hippen","year":"2018","journal-title":"Am J Transplant"},{"issue":"13","key":"10.1016\/j.transproceed.2026.02.014_bib0025","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jama.2020.0704","article-title":"Medicare enrollment among patients with end-stage kidney disease receiving dialysis in outpatient facilities between 2005 and 2016","volume":"323","author":"Hoffman","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.transproceed.2026.02.014_bib0026","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1097\/TXD.0000000000001056","article-title":"Financial evaluation of kidney transplant with hepatitis C viremic donors to uninfected recipients","volume":"6","author":"Axelrod","year":"2020","journal-title":"Transplant Direct"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:17:40Z","timestamp":1779164260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134526000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0041134526000977"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.02.014","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Hepatitis C Virus\u2013Negative Recipients of a Hepatitis C Virus\u2013Infected Donor Kidney, Direct Antiviral Agent Therapy for 8 Weeks Is Noninferior to 12 Weeks","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}